Código QR

Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients

József Attila Szász,1,2,* Viorelia Adelina Constantin,2,3,* Károly Orbán-Kis,1,2 Attila Rácz,4 Ligia Ariana Bancu,1,5 Dan Georgescu,1,6 János Szederjesi,1,7 István Mihály,1,2 Ana-Mária Fárr,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Szász JA, Constantin VA, Orbán-Kis K, Rácz A, Bancu LA, Georgescu D, Szederjesi J, Mihály I, Fárr AM, Kelemen K, Vajda T, Szatmári S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	advanced parkinson’s disease motor complications levodopa doses levodopa-carbidopa intestinal gel. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f29fdc410a0f4acbb18ccdf17f799531
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Comparación farmacocinética de Sinemetây Grifoparkinâ (levodopa/carbidopa 250/25 mg) en pacientes con enfermedad de Parkinson avanzada: un estudio con dosis única
por: Chaná C,Pedro, et al.
Publicado: (2003)

Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients
por: Constantin VA, et al.
Publicado: (2020)

Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients
por: Szász JA, et al.
Publicado: (2019)

Levodopa en la enfermedad de Parkinson: ¿Qué hemos aprendido?
por: Juri C,Carlos, et al.
Publicado: (2006)

Consideraciones sobre las complicaciones motoras y neurotoxicidad de la levodopa en la enfermedad de Parkinson
por: Venegas F.,Pablo
Publicado: (2005)

Síndrome neuroléptico maligno-like como complicación en enfermedad de Parkinson: Desenlace fatal. Reporte de un caso y revisión de la literatura
por: Salinas S,Carlos, et al.
Publicado: (2014)

Von Economo’s disease and postencephalitic parkinsonism responsive to carbidopa and levodopa
por: Bigman DY, et al.
Publicado: (2018)

DEVELOPMENT OF A MODIFIED CARBON ELECTRODE WITH IONIC LIQUID AND ITS APPLICATION FOR ELECTROCATALYTIC OXIDATION AND VOLTAMMETRIC DETERMINATION OF LEVODOPA
por: MONCADA,V, et al.
Publicado: (2014)

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden
por: Modugno N, et al.
Publicado: (2020)

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease
por: Hauser RA, et al.
Publicado: (2018)

Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
por: Werner Poewe, et al.
Publicado: (2010)

Electrocatalytic determination of levodopa in presence of cabergoline using carbon paste electrode modified with graphene quantum dots/2-chlorobenzoyl ferrocene/ionic liquid
por: Peyman Mohammadzadeh Jahani
Publicado: (2021)

Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats
por: Cao,Xuebing, et al.
Publicado: (2016)

A comparison between Bromocriptine and Selegiline in treatment of Parkinsons disease
por: A Ahmadi Ahangar, et al.
Publicado: (2002)

Disposable and low-cost lab-made screen-printed electrodes for voltammetric determination of L-dopa
por: Jefferson H.S. Carvalho, et al.
Publicado: (2021)

The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]
por: Hinz M, et al.
Publicado: (2021)

The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]
por: Hinz M, et al.
Publicado: (2020)

Relationships between Freezing of Gait Severity and Cognitive Deficits in Parkinson’s Disease
por: Jamie L. Scholl, et al.
Publicado: (2021)

The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
por: José-Francisco Rocha, et al.
Publicado: (2021)

Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
por: Noham Wolpe, et al.
Publicado: (2018)

Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease
por: Hirofumi Matsuyama, et al.
Publicado: (2021)

Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease
por: Daniel D Truong
Publicado: (2009)

Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia
por: Takada R, et al.
Publicado: (2018)

Efficacy and motor complications of original and generic levodopa in Parkinson's disease treatment
por: Kasemsap N, et al.
Publicado: (2016)

Protein intake and the use of levodopa in patients with Parkinson's disease
por: de Moraes Fracasso,Bianca, et al.
Publicado: (2013)

Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date
por: Patel AB, et al.
Publicado: (2018)

The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats
por: Wu N, et al.
Publicado: (2018)

A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons
por: Gha-Hyun J Kim, et al.
Publicado: (2021)

Levodopa-Loaded 3D-Printed Poly (Lactic) Acid/Chitosan Neural Tissue Scaffold as a Promising Drug Delivery System for the Treatment of Parkinson’s Disease
por: Ezgi Saylam, et al.
Publicado: (2021)

Effects of Carbidopa Premedication on <sup>18</sup>F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis
por: Marie Bros, et al.
Publicado: (2021)

Diagnostic pitfalls in a young Romanian ranger with an acute psychotic episode
por: Nagy EE, et al.
Publicado: (2016)

Parkinson’s disease managing reversible neurodegeneration
por: Hinz M, et al.
Publicado: (2016)

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
por: Hinz M, et al.
Publicado: (2020)

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
por: Hinz M, et al.
Publicado: (2020)

INFLUENCE OF PURIFICATION PROCESS ON THE CHARACTERISTICS OF ROMANIAN CALCIUM BENTONITE
por: ANA-MARIA GEORGESCU, et al.
Publicado: (2016)

Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development
por: Diana Miclea, et al.
Publicado: (2021)

Allelic distribution of BDNF Val66Met polymorphism in healthy Romanian volunteers
por: Vulturar Romana, et al.
Publicado: (2016)

Romanian neurosurgery
Publicado: (1992)

Romanian Journal of Psychology

Romanian Journal of Rhinology